Planing to attend? Save $700 on your ticket with super early-bird pricing ($800) + 3-for-the-price-of-2 group packs available. Offer ends in:
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
The next generation of drug product development
and manufacturing technology is here…
Now in it’s 11th year, the popular 2025 Summit on Innovations in Controlled Release, Bioavailability Enhancement & Continuous Manufacturing returns this May.
Connect with 160+ senior drug development innovators and uncover industry’s latest formulation, product development and delivery technologies for improving performance and manufacuring capabilities.
2025’s Summit covers Controlled & Modified Drug Release, Drug Bioavailability Enhancement and Continuous Manufacturing technologies and capabilities.
✅ 2 full tracks of technical talks, panels and thought-provoking discussion sessions
✅ Network with 100’s of senior development, formulation and manufacturing attendees and solution providers
✅ Multiple exhibits, banquet lunches and dinners, workshops, exhibits, champagne giveaways and networking receptions
✅ Access all sessions post-Summit on-demand so you can relive your best moments
✅ Be part of our community of drug product development experts which will open many doors in the future.
40+
Industry-led Speakers
160+
Senior Attendees
2
Tracked Streams
14+
Networking Hours
18
Solution Providers
- High Dose Subcutaneous Delivery: Roadmap from Pre-clinical to Launch
- How To Accelerate Drug Product Optimization: Integrated Program Delivery using Translational Pharmaceutics
- Percolation Behavior in an Immediate Release Tablet Dosage Form
- Long-Acting Implant Product Development
- The competences and Intricacies of Fluid Bed Technologies
- Formulation of LAI: Understanding what Attributes Control Injectability
- The Impact of Excipient Selection on Modified Release Profiles
- Co-Excipient Strategies for Controlled Release Formulations
- Advancing Oral Modified Delivery for Rare Diseases via Lipid Based formulations
- Streamlining SC Biologics Drug Development
- Using PBPK Modeling for Risk Assessment in Drug Product Development
- Efficient New Tools for Solubility Enhancement and Lifecycle Management
- High Dose Subcutaneous Delivery: Roadmap from Pre-clinical to Launch
- Translational Formulation Approaches for the Oral Delivery of eRo5/bRo5 – Molecules
- Strategies for ASD Formulation Development
- Leveraging Melt-Spray-Congeal Microspheres as a Versatile, Patient-centric Oral Multiparticulate Platform
- Cellular Model of the Oral Lymphatic Absorption Pathway
- Topical Ophthalmic Drug Delivery: Insights from Marketed Products
- Oral Delivery of Peptides: Challenges and Opportunities
- And much more..
2024 Speakers Included
Joe Della Rocca, PhD
Associate Principal Scientist
Merck
Anand Uhbe, PhD
Senior Scientist (II), Sterile Liquids Product Development
Abbvie
Dipy Vasa, PhD
Principal Scientist, Drug Product Dev
Pfizer
Ryan Pelis, PhD
Sr. Principal Scientist, Pharmacokinetic Sciences
Novartis
Kellyn Zagaja, PhD
Principal Scientist, Drug Product Design
Pfizer
Siddharth S. Kesharwani, PhD
Biopharmaceutics Scientist
Sanofi
Indrajit Ghosh, PhD
Scientific Director, Biologics Product Development
Bristol Myers Squibb
Aruna Railkar, PhD
Senior Research Fellow
Quotient Sciences
Seth Forster, PhD
Associate Principal Scientist
Merck
Girish Nihalani, PhD
Research Fellow, Product Development
Teva Pharmaceuticals
Liliana Miinea, PhD
Global Technology Manager, Pharmaceutical Excipients
Lubrizol
Kelly Zhang, PhD
Senior Scientist, Analytical Enabling Capabilities – MBC | Analytical Research & Development
Merck
Misha Murashov, PhD
Assoc Prin. Scientist, Sterile & Specialty Products BDB
Merck
Prajwal Thool
Scientist III, Drug Product Development
Genentech
Zafar Iqbal, PhD
Vice President & Head of Pharmaceutical Development
Glatt Group
Jim Baxter
NA Technical Business Development Manager
Lubrizol Life Science
Firouz Asgarzadeh, PhD
President of Consulting Services
OSD Pharmaceutical Solutions
Vivek Gupta, PhD
Associate Professor, Pharmaceutical Sciences
St. John’s University
Erica Schlesinger, PhD
Vice President of Technical Development
Seran Biosciences
Ketan Patel, PhD
Associate Professor of Pharmaceutics
St. John’s University
Previous Sponsors & Exhibitors
Download The Controlled Release Previous Attendee List
Partnering with the 2025 Summit will also help you:
- Enhance commercial relationships with existing clients through platform interaction, meetings, and discussing the latest opportunities
- Raise your brand awareness to a captive and engaging audience, which most-of-all encompasses decision-making criteria
- Elevate your profile amongst industry peers and developing a contact base through 1-2-1 networking sessions
- Generate direct new business opportunities from senior-level attendees with decision-making criteria currently sourcing drug product development solutions
"*" indicates required fields
Registration Pricing:
Super Early-Bird
Register Before November 29, 2024
Regular Attendance
$900
3-for-2 Group Pack
$1800
On-Demand
$595
Early-Bird Rate
Register Before Jan 31, 2025
Regular Attendance
$1100
3-for-2 Group Pack
$2200
On-Demand
$595
ONSITE PRICING
Register March 22, 2025 Onwards
Regular Attendance
$1600
3-for-2 Group Pack
$3200
On-Demand
$795